Donate
Individualized neoantigen-targeted vaccines for lung cancer
With Joline INGELS
DATE & TIME : Thursday, June 18, 2026 I 4:00 PM CET
Moderators : Samuel BITOUN, François‑Xavier DANLOS
Transdisciplinary Immunology Journal Club — #TIJC 19
Joline Ingels, PhD, is Head of Production at the Cell & Gene Therapy facility of Ghent University Hospital. Her work focuses on advanced therapy medicinal products, including neoantigen‑based cancer vaccines, building on her doctoral research in immunomonitoring of lung cancer patients.
This session will explore how neoadjuvant chemo‑immunotherapy reshapes the immune landscape of tumor‑draining lymph nodes in NSCLC, with emphasis on antigen‑presenting cell states, T‑cell trajectories, clonal dynamics, and spatial immune circuits.